trending Market Intelligence /marketintelligence/en/news-insights/trending/-BQEqoJcs3FjVT29EwDUJg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Boston Scientific signs $700M loan agreement


Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection


Banking Essentials Newsletter - February Edition


Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Boston Scientific signs $700M loan agreement

Boston Scientific Corp. entered a $700 million credit agreement with certain lenders.

The agreement provides for a $700 million 364-day term loan that will mature Dec. 3, 2020, at the London interbank offered rate plus a margin of 0.65%.

The Marlborough, Mass.-based medical device maker said in an SEC filing the loan will be used to repay the remaining amounts outstanding under an earlier $2 billion credit agreement, among other things.

Boston Scientific is required to maintain a maximum leverage ratio of 3.75x, among other things as part of the new credit arrangement.

Wells Fargo Bank NA is the syndication agent, while Bank of Nova Scotia and Wells Fargo Securities LLC are joint lead arrangers and joint book runners. Bank of Nova Scotia is also serving as administrative agent.